Clinical Trials

406 enrolled 11 charts

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00421317 2026-03-13

O-Mel-Inib

Phase 2 Terminated

13 enrolled

Dermatologic

Melanoma

NCT03516279 2026-03-02

Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease

Other hematologic neoplasm

40 enrolled

Leukemia, Myeloid, Chronic-Phase, Neoplasm, Residual

NCT05493215 2026-02-17

Imatinib TDM in GIST

28 enrolled

Phase 2 Not yet recruiting

Gastrointestinal Stromal Tumors

NCT07406633 2026-02-12

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting

46 enrolled

Digestive System Neoplasms, Gastrointestinal Stromal Tumors

NCT05152472 2026-01-08

ATEZOGIST

110 enrolled

Neoplasms, Gastrointestinal Stromal Tumors

NCT04626024 2025-12-19

TOKIN

100 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT03654768 2025-12-18

Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia

Other hematologic neoplasm

81 enrolled 20 charts

Leukemia, Myeloid, Chronic-Phase

NCT04070443 2025-11-18

TIPI

170 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT03578367 2025-11-10

Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Phase 2 Completed

104 enrolled 11 charts

Hematologic Diseases, Leukemia, Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT04598009 2025-09-03

Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma

25 enrolled

Dermatologic

Melanoma

NCT00015847 2025-08-22

Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia

Phase 2 Terminated

25 enrolled 8 charts

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT05385549 2025-08-08

5 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High Risk

35 enrolled

Gastrointestinal Stromal Tumors

NCT04838041 2025-07-30

Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

51 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00476190 2025-06-12

ALL Adult Consortium Trial: Adult ALL Trial

Phase 2 Completed

112 enrolled 17 charts

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06119789 2025-03-26

MATRIX-Rare